Trial Information

Summary: Hypertension Study CVAA489AUS02

The purpose of this clinical research study is to compare the medium dose of an FDA approved combination drug with the higher dose of an FDA approved combination drug on blood pressure control in patients who have failed to have their blood pressure controlled on a single antihypertensive agent. An FDA approved combination drug in this instance is referring to, two antihypertensive medications in one pill that has been tested and is approved for sale in the United States by the U.S. Food and Drug Administration (FDA).

The study will last at least 13 weeks with participants required to visit the study center at least 6 times but up to 7 times. Some participants will be asked to wear an ambulatory blood pressure monitoring device for approximately 24 hours at 3 visits. Wearing this device involves fastening it to the side of the body and placing a cuff around the arm. The cuff automatically inflates and deflates several times per hour to measure blood pressure. These participants will come to the study center 9 times over 17 weeks.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: August 28, 2008 at 3:00:23 PM